Harrington, Patrick http://orcid.org/0000-0001-5704-466X
de Lavallade, Hugues
Doores, Katie J.
O’Reilly, Amy http://orcid.org/0000-0002-5346-754X
Seow, Jeffrey
Graham, Carl
Lechmere, Thomas
Radia, Deepti
Dillon, Richard
Shanmugharaj, Yogita
Espehana, Andreas http://orcid.org/0000-0003-2872-6826
Woodley, Claire
Saunders, Jamie http://orcid.org/0000-0002-8650-5362
Curto-Garcia, Natalia
O’Sullivan, Jennifer
Raj, Kavita
Kordasti, Shahram
Malim, Michael H.
Harrison, Claire N.
McLornan, Donal P. http://orcid.org/0000-0003-1224-091X
Funding for this research was provided by:
European and Developing Countries Clinical Trials Partnership (RIA2020EF-3008 COVAB)
Article History
Received: 23 April 2021
Revised: 4 May 2021
Accepted: 12 May 2021
First Online: 22 May 2021
Compliance with ethical standards
:
: PH reports research funding from Bristol Myers Squibb and speakers fees from Incyte. HdL has received research grants and honoraria from Incyte and honoraria from Novartis and Pfizer. CH has received speaker fees from Novartis, Jannsen, CTI, Celgene, Medscape and has served on the Advisory Board for Incyte, CTI, Sierra Oncology, Novartis, Celgene, Roche, AOP pharma, Geron and Astra Zenica. DM has received speaker fees and advisory boards Novartis, Celgene and Jazz pharmaceuticals.
Free to read: This content has been made available to all.